These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 31764824)

  • 1. Diffusion-weighted image improves detectability of magnetic resonance cholangiopancreatography for pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm.
    Kawakami S; Fukasawa M; Shimizu T; Ichikawa S; Sato T; Takano S; Kadokura M; Shindo H; Takahashi E; Hirose S; Fukasawa Y; Hayakawa H; Nakayama Y; Yamaguchi T; Inoue T; Maekawa S; Kawaida H; Motosugi U; Onishi H; Enomoto N
    Medicine (Baltimore); 2019 Nov; 98(47):e18039. PubMed ID: 31764824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Added value of diffusion-weighted imaging to MR cholangiopancreatography with unenhanced mr imaging for predicting malignancy or invasiveness of intraductal papillary mucinous neoplasm of the pancreas.
    Kang KM; Lee JM; Shin CI; Baek JH; Kim SH; Yoon JH; Han JK; Choi BI
    J Magn Reson Imaging; 2013 Sep; 38(3):555-63. PubMed ID: 23390008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The diagnostic value of abbreviated MRI protocol in the surveillance of Branch-Duct intraductal papillary mucinous neoplasm.
    Malekzadeh S; Cannella R; Fournier I; Hiroz P; Mottet C; Constantin C; Widmer L
    Eur J Radiol; 2024 Jun; 175():111455. PubMed ID: 38608499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of 3-T MR imaging in intraductal papillary mucinous neoplasm with a concomitant invasive carcinoma.
    Sotozono H; Kanki A; Yasokawa K; Yamamoto A; Sanai H; Moriya K; Tamada T
    Eur Radiol; 2022 Dec; 32(12):8276-8284. PubMed ID: 35665843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of EUS in early detection of pancreatic ductal adenocarcinomas in patients with intraductal papillary mucinous neoplasms.
    Kamata K; Kitano M; Kudo M; Sakamoto H; Kadosaka K; Miyata T; Imai H; Maekawa K; Chikugo T; Kumano M; Hyodo T; Murakami T; Chiba Y; Takeyama Y
    Endoscopy; 2014 Jan; 46(1):22-9. PubMed ID: 24218310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does secretin stimulation add to magnetic resonance cholangiopancreatography in characterising pancreatic cystic lesions as side-branch intraductal papillary mucinous neoplasm?
    Purysko AS; Gandhi NS; Walsh RM; Obuchowski NA; Veniero JC
    Eur Radiol; 2014 Dec; 24(12):3134-41. PubMed ID: 25100335
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance (MR) for mural nodule detection studying Intraductal papillary mucinous neoplasms (IPMN) of pancreas: Imaging-pathologic correlation.
    D'Onofrio M; Tedesco G; Cardobi N; De Robertis R; Sarno A; Capelli P; Martini PT; Giannotti G; Beleù A; Marchegiani G; Gobbo S; Butturini G; Bogdan M; Salvia R; Bassi C
    Pancreatology; 2021 Jan; 21(1):180-187. PubMed ID: 33376061
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Magnetic resonance cholangiopancreatography with compressed sensing at 1.5 T: clinical application for the evaluation of branch duct IPMN of the pancreas.
    Henninger B; Steurer M; Plaikner M; Weiland E; Jaschke W; Kremser C
    Eur Radiol; 2020 Nov; 30(11):6014-6021. PubMed ID: 32556465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Malignant Potential in Intraductal Papillary Mucinous Neoplasms of the Pancreas: Comparison between Multidetector CT and MR Imaging with MR Cholangiopancreatography.
    Kang HJ; Lee JM; Joo I; Hur BY; Jeon JH; Jang JY; Lee K; Ryu JK; Han JK; Choi BI
    Radiology; 2016 Apr; 279(1):128-39. PubMed ID: 26517448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of diffusion-weighted MRI for differentiating malignant from benign intraductal papillary mucinous neoplasms of the pancreas.
    Jang KM; Kim SH; Min JH; Lee SJ; Kang TW; Lim S; Choi D
    AJR Am J Roentgenol; 2014 Nov; 203(5):992-1000. PubMed ID: 25341136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of endoscopic retrograde pancreatography for early detection of pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm of the pancreas.
    Ohtsuka T; Ideno N; Aso T; Nagayoshi Y; Kono H; Mori Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M
    J Hepatobiliary Pancreat Sci; 2013 Mar; 20(3):356-61. PubMed ID: 22878836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between hyperechogenic pancreas and pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasms.
    Mandai K; Uno K; Nakase K; Kawamura T; Yasuda K
    J Med Ultrason (2001); 2019 Oct; 46(4):435-439. PubMed ID: 31069577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Comparison of enhanced magnetic resonance imaging and magnetic resonance cholangiopancreatography in the differential diagnosis of benign and malignant intraductal papillary mucinous neoplasms of the pancreas].
    Qian HF; Li FQ; Hu CH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2014 Feb; 36(1):98-101. PubMed ID: 24581137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic accuracy of diffusion restriction in intraductal papillary mucinous neoplasm of the pancreas in comparison with "high-risk stigmata" of the 2012 international consensus guidelines for prediction of the malignancy and invasiveness.
    Kim M; Mi Jang K; Kim SH; Doo Song K; Jeong WK; Kang TW; Kim YK; Cha DI; Kim K; Yoo H
    Acta Radiol; 2017 Oct; 58(10):1157-1166. PubMed ID: 28084815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI Combined with Magnetic Resonance Cholangiopancreatography for Diagnosis of Benign and Malignant Pancreatic Intraductal Papillary Mucinous Neoplasms.
    Liu X; Xu W; Liu Z; Ye J
    Curr Med Imaging Rev; 2019; 15(5):504-510. PubMed ID: 32008558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Feasibility of Abbreviated Magnetic Resonance With Breath-Hold 3-Dimensional Magnetic Resonance Cholangiopancreatography for Surveillance of Pancreatic Intraductal Papillary Mucinous Neoplasm.
    Kang HJ; Lee DH; Lee JM; Yoo J; Weiland E; Kim E; Son Y
    Invest Radiol; 2020 May; 55(5):262-269. PubMed ID: 32073419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agreement among Magnetic Resonance Imaging/Magnetic Resonance Cholangiopancreatography (MRI-MRCP) and Endoscopic Ultrasound (EUS) in the evaluation of morphological features of Branch Duct Intraductal Papillary Mucinous Neoplasm (BD-IPMN).
    Uribarri-Gonzalez L; Keane MG; Pereira SP; Iglesias-García J; Dominguez-Muñoz JE; Lariño-Noia J
    Pancreatology; 2018 Mar; 18(2):170-175. PubMed ID: 29338919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of unenhanced MRI with diffusion-weighted imaging for detection of primary small (≤20 mm) solid pancreatic tumours and prediction of pancreatic ductal adenocarcinoma.
    Park HJ; Jang KM; Song KD; Kim SH; Kim YK; Cha MJ; Choi SY; Min K
    Clin Radiol; 2017 Dec; 72(12):1076-1084. PubMed ID: 28784320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Another dimension in magnetic resonance cholangiopancreatography: comparison of 2- and 3-dimensional magnetic resonance cholangiopancreatography for the evaluation of intraductal papillary mucinous neoplasm of the pancreas.
    Yoon LS; Catalano OA; Fritz S; Ferrone CR; Hahn PF; Sahani DV
    J Comput Assist Tomogr; 2009; 33(3):363-8. PubMed ID: 19478628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraductal papillary mucinous neoplasm of pancreas: multi-detector row CT with 2D curved reformations--correlation with MRCP.
    Sahani DV; Kadavigere R; Blake M; Fernandez-Del Castillo C; Lauwers GY; Hahn PF
    Radiology; 2006 Feb; 238(2):560-9. PubMed ID: 16436817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.